93 related articles for article (PubMed ID: 10791215)
1. The role of vitamin D3 receptor mRNA in the proliferation of hepatocellular carcinoma.
Miyaguchi S; Watanabe T
Hepatogastroenterology; 2000; 47(32):468-72. PubMed ID: 10791215
[TBL] [Abstract][Full Text] [Related]
2. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression.
Campbell MJ; Gombart AF; Kwok SH; Park S; Koeffler HP
Oncogene; 2000 Oct; 19(44):5091-7. PubMed ID: 11042697
[TBL] [Abstract][Full Text] [Related]
3. Lipopolysaccharide negatively modulates vitamin D action by down-regulating expression of vitamin D-induced VDR in human monocytic THP-1 cells.
Pramanik R; Asplin JR; Lindeman C; Favus MJ; Bai S; Coe FL
Cell Immunol; 2004; 232(1-2):137-43. PubMed ID: 15876428
[TBL] [Abstract][Full Text] [Related]
4. Amphiregulin is a vitamin D3 target gene in squamous cell and breast carcinoma.
Akutsu N; Bastien Y; Lin R; Mader S; White JH
Biochem Biophys Res Commun; 2001 Mar; 281(4):1051-6. PubMed ID: 11237771
[TBL] [Abstract][Full Text] [Related]
5. [Effects of vitamin D analogue EB1089 on proliferation and apoptosis of hepatic carcinoma cells].
Luo WJ; Chen JY; Xu W; Zhao F; Chen YM; Shen XF
Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Nov; 38(6):415-8. PubMed ID: 15569516
[TBL] [Abstract][Full Text] [Related]
6. The E1A oncogene induces resistance to the effects of 1,25-dihydroxyvitamin D3 on inhibition of growth of mouse keratinocytes.
Park K; Bae H; Heydemann A; Roberts AB; Dotto GP; Sporn MB; Kim SJ
Cancer Res; 1994 Dec; 54(23):6087-9. PubMed ID: 7954451
[TBL] [Abstract][Full Text] [Related]
7. 1,25(OH)2D3 and dihydrotestosterone interact to regulate proliferation and differentiation of epiphyseal chondrocytes.
Krohn K; Haffner D; Hügel U; Himmele R; Klaus G; Mehls O; Schaefer F
Calcif Tissue Int; 2003 Oct; 73(4):400-10. PubMed ID: 12874696
[TBL] [Abstract][Full Text] [Related]
8. [Synergistic inhibitory effect of all-trans retinoic acid and 1,25-dihydroxy vitamin D3 on growth of human hepatoma cell line HepG2].
Lu HQ; Zheng J
Ai Zheng; 2006 Dec; 25(12):1470-6. PubMed ID: 17166369
[TBL] [Abstract][Full Text] [Related]
9. Identification of VDR-responsive gene signatures in breast cancer cells.
Towsend K; Trevino V; Falciani F; Stewart PM; Hewison M; Campbell MJ
Oncology; 2006; 71(1-2):111-23. PubMed ID: 17377416
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of vitamin D receptor indicates a good prognosis for cholangiocarcinoma: implications for therapeutics.
Seubwai W; Wongkham C; Puapairoj A; Khuntikeo N; Wongkham S
Cancer; 2007 Jun; 109(12):2497-505. PubMed ID: 17487855
[TBL] [Abstract][Full Text] [Related]
11. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
Swami S; Krishnan AV; Feldman D
Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
[TBL] [Abstract][Full Text] [Related]
12. 1,25-Dihydroxyvitamin D3 up-regulates the renal vitamin D receptor through indirect gene activation and receptor stabilization.
Healy KD; Frahm MA; DeLuca HF
Arch Biochem Biophys; 2005 Jan; 433(2):466-73. PubMed ID: 15581603
[TBL] [Abstract][Full Text] [Related]
13. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells.
Sertznig P; Dunlop T; Seifert M; Tilgen W; Reichrath J
Anticancer Res; 2009 Sep; 29(9):3647-58. PubMed ID: 19667161
[TBL] [Abstract][Full Text] [Related]
14. Differential biological effects of 1,25-dihydroxyVitamin D3 on melanoma cell lines in vitro.
Seifert M; Rech M; Meineke V; Tilgen W; Reichrath J
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):375-9. PubMed ID: 15225804
[TBL] [Abstract][Full Text] [Related]
15. 1,25-Dihydroxyvitamin D3 receptor as a marker of human colon carcinoma cell line differentiation and growth inhibition.
Shabahang M; Buras RR; Davoodi F; Schumaker LM; Nauta RJ; Evans SR
Cancer Res; 1993 Aug; 53(16):3712-8. PubMed ID: 8393379
[TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma.
Ikeguchi M; Hirooka Y; Kaibara N
Cancer; 2002 Nov; 95(9):1938-45. PubMed ID: 12404288
[TBL] [Abstract][Full Text] [Related]
17. Calbindin-D28k (CaBP28k) identification and regulation by 1,25-dihydroxyvitamin D3 in human choriocarcinoma cell line JEG-3.
Belkacemi L; Züegel U; Steinmeyer A; Dion JP; Lafond J
Mol Cell Endocrinol; 2005 May; 236(1-2):31-41. PubMed ID: 15922086
[TBL] [Abstract][Full Text] [Related]
18. Identification of ROBO1 as a novel hepatocellular carcinoma antigen and a potential therapeutic and diagnostic target.
Ito H; Funahashi S; Yamauchi N; Shibahara J; Midorikawa Y; Kawai S; Kinoshita Y; Watanabe A; Hippo Y; Ohtomo T; Iwanari H; Nakajima A; Makuuchi M; Fukayama M; Hirata Y; Hamakubo T; Kodama T; Tsuchiya M; Aburatani H
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3257-64. PubMed ID: 16740745
[TBL] [Abstract][Full Text] [Related]
19. [Overexpression and genomic amplification of decoy receptor 3 in hepatocellular carcinoma and significance thereof].
Shen HW; Wu YL; Peng SY
Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):744-7. PubMed ID: 12899749
[TBL] [Abstract][Full Text] [Related]
20. Effects of 1,25(OH)2D3, EB1089, and analog V on PTHrP production, PTHrP mRNA expression and cell growth in SCC 2/88.
Kunakornsawat S; Rosol TJ; Capen CC; Middleton RP; Hannah SS; Inpanbutr N
Anticancer Res; 2001; 21(5):3355-63. PubMed ID: 11848494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
